Dianthus Therapeutics (DNTH) Cash & Equivalents Growth (3y) (2020 - 2025)
Dianthus Therapeutics (DNTH) Cash & Equivalents Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 13.29% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 10.63% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -16.07% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -8.88% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Dianthus Therapeutics | 3.92 Bn | 3.51 Bn | - | 48.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 48.43% |
| Sep 30, 2025 | 14.25% |
| Jun 30, 2025 | -37.73% |
| Mar 31, 2025 | -47.96% |
| Dec 31, 2024 | -44.96% |
| Sep 30, 2024 | -40.21% |
| Jun 30, 2024 | 26.55% |
| Mar 31, 2024 | 88.42% |
| Dec 31, 2023 | 31.53% |
| Sep 30, 2023 | 3.54% |
| Jun 30, 2023 | -33.39% |
| Mar 31, 2023 | -32.34% |
| Dec 31, 2022 | -38.19% |
| Sep 30, 2022 | -24.44% |
| Jun 30, 2022 | 18.31% |
| Mar 31, 2022 | 31.95% |
| Dec 31, 2021 | 31.16% |
| Sep 30, 2021 | -0.45% |
| Jun 30, 2021 | -3.67% |
| Dec 31, 2020 | 4.20% |